During the past decade, Sadick Research Group conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 23 clinical trials were completed, i.e. on average, 60.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 16 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sadick Research Group" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Venus Concept" with 5 trials sponsored, "Sadick Research Group" with 4 trials sponsored, "Amgen" with 2 trials sponsored and "Cassiopea SpA" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sadick Research Group" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "Episciences, Inc." with 1 trials as a collaborator and "Neothetics, Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sadick Research Group" are "Atopic Dermatitis" (9 trials), "Acne Vulgaris" (4 trials), "Plaque Psoriasis" (4 trials), "Psoriasis" (3 trials) and "Acne Scars" (2 trials). Many other conditions were trialed in "Sadick Research Group" in a lesser frequency.

Most popular intervention types in "Sadick Research Group" are "Drug" (27 trials), "Device" (15 trials), "Other" (8 trials), "Biological" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Lebrikizumab" (6 trials), "Apremilast" (3 trials), "Venus Viva" (3 trials) and "CB-03-01 cream, 1%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sadick Research Group" are 40 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Sadick Research Group". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Sadick Research Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sadick Research Group, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 12 trials that are defined as “Not Applicable".